2025-ben immáron 8. alkalommal kerül megrendezésre az Onko-Kardiológiai Napok Továbbképző Kongresszus 2025. április 25-26. között a konferencia állandó helyszínén, a Four Points By Sheraton Kecskemét Hotel és Konferenciaközpontban.

A konferencia kiemelt témái:
– szubklinikus kardiotoxicitás,
– az irányelveken túlmutató komplexitású helyzetek egyénre szabott beteg managementje,
– onko-pulmonológia,
– határterületi kérdések,
– bioetika,
– hazai onko-kardiológiai kutatások.

Az elmúlt évekhez hasonlóan külföldi vendégelőadó is tiszteletét teszi rendezvényünkön, idén Dr. Thomas Allison személyében (Mayo Clinic, Rochester), aki érdekes onko-kardiológiai vonatkozású esettanulmányait osztja majd meg a közönséggel. A hagyományokhoz hűen lesznek esetbemutatások és interaktív onkoteam, valamint hazai onko-kardiológiai kutatásokat bemutató szekció is, melyben idén először kerül átadásra a Fiatal Kutatói Díj.

A kongresszus 22 kreditpontra akkreditált az alábbi szakmák dolgozóinak: belgyógyászat, bőrgyógyászat, haematológia, háziorvostan, kardiológia, klinikai onkológia, sugárterápia, orvosi rehabilitáció (kardiológia), radiológia, tüdőgyógyászat, urológia.

A konferenciáról bővebb információ az alábbi oldalon található:
WEBOLDAL
SZAKMAI PROGRAM
RÉSZVÉTELI DÍJAK

Szeretettel várjuk a szakmai rendezvényen!

A Magyar Onko-kardiológiai Munkacsoport Egyesület nevében a
konferencia Szervező és Tudományos Bizottsága:

Vezető:
Dr. Czuriga Dániel PhD., med. habil.
Tagok: 
Dr. Torday László PhD.
Dr. Pozsonyi Zoltán PhD.
Dr. Rubovszky Gábor PhD.
Dr. Hornyák Lajos PhD.
Dr. Fogarassy György PhD.
Dr. Drobni Zsófia PhD.
Dr. Szőllősi Regő
Dr. Kocsis Judit PhD., med. habil.
Dr. Nagy András Csaba PhD.

Kongresszusszervező iroda:
Club Service Kft. 
E-mail: onkokardio2025@clubservice.hu

European Society for Pediatric Dermatology (ESPD)

General Information & Deadlines

1.Abstracts MUST be submitted electronically via the online submission system by the given deadline of Wednesday, 4 January 2023.

Abstracts received via fax, e-mail or received after the deadline will not be accepted and therefore will not be considered for the programme or publication.

2. Abstracts need to be submitted into the following topics:

• ATOPIC AND OTHER DERMATITIDES
• AUTOIMMUNE DISEASES
• BLISTERING/ICHTHYOSIS
• GENODERMATOSES
• INFECTIOUS
• INFLAMMATORY
• MISCELLANEOUS
• NEONATAL
• NEOPLASTIC / TUMORAL
• PIGMENTARY DISORDERS, NAEVI AND OTHER MOSAICS
• TREATMENT
• VASCULAR ANOMALIES & OVERGROWTH

3. A preferred presentation method should be selected during the submission from the following options:

• Oral Presentation
• Poster Presentation 

Please note, oral presentations will be presented mainly in the Oral Communications Parallel Sessions, possibly also in sessions The Training Program and Future Leaders.

4. Once the abstract is “submitted” it can be changed until the Abstract Submission Deadline of 4 January 2023.

5. All abstracts will be reviewed by the ESPD Scientific Committee who will consider its formal aspects and the content. They will decide which abstracts will be accepted.

6. Accepted abstracts will be published in the online Abstract Book. Abstracts not suitable for display will be rejected. Please have your abstract checked for correct spelling, punctuation, grammar and formal structure. The organiser reserves the right to edit abstracts if necessary prior to the publication in the online ESPD Congress Abstract Book.

7. All presenting authors will receive an acceptance/rejection notification via e-mail by 31 January 2023.

8. All presenting authors are obliged to register by Tuesday, 21 February 2023.

European Society for Pediatric Dermatology (ESPD)

General Information & Deadlines

1.Abstracts MUST be submitted electronically via the online submission system by the given deadline of Wednesday, 4 January 2023.

Abstracts received via fax, e-mail or received after the deadline will not be accepted and therefore will not be considered for the programme or publication.

2. Abstracts need to be submitted into the following topics:

• ATOPIC AND OTHER DERMATITIDES
• AUTOIMMUNE DISEASES
• BLISTERING/ICHTHYOSIS
• GENODERMATOSES
• INFECTIOUS
• INFLAMMATORY
• MISCELLANEOUS
• NEONATAL
• NEOPLASTIC / TUMORAL
• PIGMENTARY DISORDERS, NAEVI AND OTHER MOSAICS
• TREATMENT
• VASCULAR ANOMALIES & OVERGROWTH

3. A preferred presentation method should be selected during the submission from the following options:

• Oral Presentation
• Poster Presentation 

Please note, oral presentations will be presented mainly in the Oral Communications Parallel Sessions, possibly also in sessions The Training Program and Future Leaders.

4. Once the abstract is “submitted” it can be changed until the Abstract Submission Deadline of 4 January 2023.

5. All abstracts will be reviewed by the ESPD Scientific Committee who will consider its formal aspects and the content. They will decide which abstracts will be accepted.

6. Accepted abstracts will be published in the online Abstract Book. Abstracts not suitable for display will be rejected. Please have your abstract checked for correct spelling, punctuation, grammar and formal structure. The organiser reserves the right to edit abstracts if necessary prior to the publication in the online ESPD Congress Abstract Book.

7. All presenting authors will receive an acceptance/rejection notification via e-mail by 31 January 2023.

8. All presenting authors are obliged to register by Tuesday, 21 February 2023.

European Society for Pediatric Dermatology (ESPD)

General Information & Deadlines

1.Abstracts MUST be submitted electronically via the online submission system by the given deadline of Wednesday, 4 January 2023.

Abstracts received via fax, e-mail or received after the deadline will not be accepted and therefore will not be considered for the programme or publication.

2. Abstracts need to be submitted into the following topics:

• ATOPIC AND OTHER DERMATITIDES
• AUTOIMMUNE DISEASES
• BLISTERING/ICHTHYOSIS
• GENODERMATOSES
• INFECTIOUS
• INFLAMMATORY
• MISCELLANEOUS
• NEONATAL
• NEOPLASTIC / TUMORAL
• PIGMENTARY DISORDERS, NAEVI AND OTHER MOSAICS
• TREATMENT
• VASCULAR ANOMALIES & OVERGROWTH

3. A preferred presentation method should be selected during the submission from the following options:

• Oral Presentation
• Poster Presentation 

Please note, oral presentations will be presented mainly in the Oral Communications Parallel Sessions, possibly also in sessions The Training Program and Future Leaders.

4. Once the abstract is “submitted” it can be changed until the Abstract Submission Deadline of 4 January 2023.

5. All abstracts will be reviewed by the ESPD Scientific Committee who will consider its formal aspects and the content. They will decide which abstracts will be accepted.

6. Accepted abstracts will be published in the online Abstract Book. Abstracts not suitable for display will be rejected. Please have your abstract checked for correct spelling, punctuation, grammar and formal structure. The organiser reserves the right to edit abstracts if necessary prior to the publication in the online ESPD Congress Abstract Book.

7. All presenting authors will receive an acceptance/rejection notification via e-mail by 31 January 2023.

8. All presenting authors are obliged to register by Tuesday, 21 February 2023.